Skip to search boxSkip to navigationSkip to main content

The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease

  • Jing He Yan(corresponding author)
    ,
  • Kenneth Ataga
    ,
  • Sanjeev Kaul
    ,
  • Jeffery S. Olson
    ,
  • Dennis M. Grasela
    ,
  • Samantha Gothelf
*Corresponding author for this work
  • Bristol-Myers Squibb
    ,
  • University of North Carolina at Chapel Hill
    ,
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>This was an open-label, nonrandomized, 2-center study conducted to assess the influence of renal function on the pharmacokinetics of hydroxyurea in adults with sickle cell disease (SCD). Seventeen patients were divided into 5 groups: normal renal function (n = 7), mild renal impairment (n = 2), moderate renal impairment (n = 3), severe renal impairment (n = 2), and end-stage renal disease (ESRD, n = 3). Except for patients with ESRD, all the patients received a 15-mg/kg single oral dose of hydroxyurea. Patients with ESRD received a 15-mg/kg oral dose of hydroxyurea on 2 occasions. Blood and urine samples were collected for the assessment of hydroxyurea pharmacokinetics. The results indicate that the systemic exposure increases and the urinary recovery decreases as the degree of renal insufficiency worsens. On the basis of the exposure and the apparent clearance from the current and 2 historical studies, the authors have proposed an initial dosing regimen of hydroxyurea (7.5 mg/kg/day) for SCD patients with CL<sub>CR</sub> <60 mL/min. This dosing strategy is anticipated to provide a safe dose for SCD patients with renal impairment.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 434-445 (12 pages)

Journal (Volume, Issue Number)

Journal of Clinical Pharmacology (Volume 45, Issue 4)

Publication milestones

  • Published - 04/2005

Publication status

Published - 04/2005

ISSN

0091-2700

Publication IDs

  • Scopus: 16844362802
  • PubMed: 15778424
  • ORCID: /0000-0002-5482-8087/work/54796917

Publication metrics

Metrics

SciVal
FWCI
1.99
SciVal
Author count
8
SciVal
citations
37
SciVal
Paper percentile
83
Scopus
citations
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
49
Captures
34

Funding Details

FunderFunding number
NHLBI
U54HL070769